Bison Ventures

Founded in 2021, Bison Ventures is a San Francisco-based venture capital firm investing in early-stage companies operating at the intersection of technology and healthcare. The firm focuses on frontier technologies that aim to improve human health and environmental sustainability.

Tom Biegala

Partner

8 past transactions

Frontera Health

Seed Round in 2025
Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases.

Bonsai Robotics

Series A in 2025
Bonsai Robotics develops vision-based automation technologies for agricultural and off-road vehicles, offering machine navigation systems powered by computer vision and artificial intelligence to enable autonomous operation. The company provides analytics and telematics for reporting and insights to help growers improve productivity, efficiency, and safety, reducing reliance on manual labor. Based in San Jose, California, Bonsai Robotics serves the farming sector with solutions that integrate autonomous navigation with data-driven decision support.

Cadstrom

Seed Round in 2024
Cadstrom develops electronic design automation tools that employ artificial intelligence. These tools facilitate real-time collaboration among engineers and designers, offering features such as rule checking, image rendering, and project management to enhance efficiency and reduce revision cycles in printed circuit board designs.

Passkey

Seed Round in 2024
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs). It is designed to address complex diseases by targeting rare combinations of proteins that work together.

Collaborative Robotics

Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

Vivodyne

Seed Round in 2023
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies. Its platform cultures human tissues in labs for realistic preclinical drug testing, using advanced AI to accelerate the creation of safe and effective therapeutics.

Allonnia

Series A in 2023
Allonnia LLC is a biotechnology company based in Boston, Massachusetts, founded in 2019, that specializes in waste remediation services. The company focuses on developing enzymes, proteins, and microbes that effectively degrade or metabolize environmental contaminants, facilitating the recovery and upcycling of valuable materials from waste. Allonnia aims to provide innovative solutions to pressing environmental challenges, including safer water and cleaner mining, while promoting sustainability. Their unique approach integrates biology with advanced technology to create systems that transform waste into useful resources. Allonnia's commitment to environmental stewardship and innovation has garnered industry recognition, positioning it as a leader in the field of biotechnology and waste management.

Vivodyne

Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies. Its platform cultures human tissues in labs for realistic preclinical drug testing, using advanced AI to accelerate the creation of safe and effective therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.